Interleukin-1 Receptor Antagonist [EPC]

11704 reported adverse events

Drugs of this class: ANAKINRA

These side effects are most commonly reported by patients taking drugs of the Interleukin-1 Receptor Antagonist [EPC] class:

# Side effect Count
0 OFF LABEL USE 3538
1 DRUG INEFFECTIVE 3127
2 RHEUMATOID ARTHRITIS 1280
3 PAIN 1213
4 JOINT SWELLING 1072
5 CONDITION AGGRAVATED 1021
6 DRUG INTOLERANCE 938
7 ARTHRALGIA 934
8 INJECTION SITE PAIN 785
9 PYREXIA 740
See all common reactions for Interleukin-1 Receptor Antagonist [EPC]

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 269 0.9150
1 INFILTRATION ANAESTHESIA 22 0.7097
2 HUMAN ANTI-HUMAN ANTIBODY TEST 16 0.6400
3 ACTINOMYCOTIC SEPSIS 8 0.5000
4 CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME 9 0.4737
5 BODY HEIGHT BELOW NORMAL 282 0.4677
6 ANKLE ARTHROPLASTY 62 0.2884
7 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 13 0.2826
8 INTESTINAL SEPSIS 42 0.2471
9 SHORT STATURE 17 0.2024
See all enriched reactions for Interleukin-1 Receptor Antagonist [EPC]